Furthermore, a recent study revealed that the increase in glutamine metabolism upon ERRα inhibition using cpd29 treatment, as we have found in the current study, is linked to reduced glutathione (GSH) production, which is involved in ROS elimination, and thus in the survival of breast cancer cells under oxidative stress [33]. The gene discussed is ESRRA; the disease is breast cancer.